Science & Technology
Science and Technology
Science and Technology
Thu, January 29, 2009 Mediware Information Systems: Mediware to Report Second Quarter 2009 Financial Results on Tuesday, February 3rd
LENEXA, KS--(Marketwire - January 29, 2009) - Mediware Information Systems, Inc. (
Individuals seeking to participate in the teleconference are encouraged to register for access online at [ http://www.directeventreg.com/registration/event/82929414 ] at least 5 minutes prior to the start of the conference. The conference ID is 82929414. Participants may also register by phone by calling toll-free 888-869-1189 (direct dial 706-643-5902) fifteen minutes prior to the call.
A replay of the call will be available after the call's completion for 5 days at 800-642-1687 (direct dial 706-645-9291). The conference ID is 82929414. After 5 days, the replay will be available on the company's web site: [ www.mediware.com ].
About Mediware
Mediware delivers blood and medication management software systems that encapsulate information supporting patient therapies, reinforce patient safety practices and improve efficiencies to lower costs. Mediware's customers include prestigious hospitals, clinics, correctional institutions, blood centers and other public and private health care institutions throughout the world. For more information about Mediware products and services, visit our web site at [ www.mediware.com ].
Certain statements in this press release may constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the "Act") and in releases made by the SEC from time to time. Such forward-looking statements are not based on historical facts and involve known and unknown risks, uncertainties and other factors disclosed in the Company's Annual Report on Form 10-K for the year ended June 30, 2008, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements. The Company disclaims any obligation to update its forward-looking statements.
